Nevro Corp. NVRO recently announced the publication of 24-month data from the SENZA Painful Diabetic Neuropathy (PDN) Randomized Controlled Trial (RCT) in Diabetes Research and Clinical Practice. The ...

Evidence Published in Diabetes Research and Clinical Practice Shows 10 kHz Therapy Yields Lasting Pain Relief and Enhances Health-Related Quality of Life and Sleep Globally, the number of people with ...

The MarketWatch News Department was not involved in the creation of this content. Real-time insights reveal BIOTRONIK Neuro's remote monitoring with remote programming led to high rates of therapy use ...

At 8 months follow-up, patients with painful diabetic peripheral neuropathy who received spinal cord stimulation (SCS) implants reported improvements in pain, neuropathic and autonomic symptoms, ...

Spinal cord stimulation (SCS) to treat pain in persons with multiple sclerosis (MS) was the focus of a recent literature review out of Italy. An analysis from Italy of 7 studies that investigated ...

The new implant is essentially a type of advanced spinal cord stimulator, which are devices that sit in between the spinal cord and the vertebrate and emit electrical pulses that disrupt pain signals.